Literature DB >> 10502539

Environmentally induced autoimmune diseases: potential mechanisms.

T Rao1, B Richardson.   

Abstract

Environmental and other xenobiotic agents can cause autoimmunity. Examples include drug-induced lupus, toxic oil syndrome, and contaminated l-tryptophan ingestion. Numerous mechanisms, based on (italic)in vitro(/italic) evidence and animal models, have been proposed to explain how xenobiotics induce or accelerate autoimmunity. The majority of these can be divided into three general categories. The first is those inhibiting the processes involved in establishing tolerance by deletion. Inhibiting deletion can result in the release of newly generated autoreactive cells into the periphery. The second mechanism is the modification of gene expression in the cells participating in the immune response, permitting lymphocytes to respond to signals normally insufficient to initiate a response or allowing the antigen-presenting cells to abnormally stimulate a response. Abnormal gene expression can thus disrupt tolerance maintained by suppression or anergy, permitting activation of autoreactive cells. The third is the modification of self-molecules such that they are recognized by the immune system as foreign. Examples illustrating these concepts are presented, and related mechanisms that have the potential to similarly affect the immune system are noted. Some mechanisms appear to be common to a variety of agents, and different mechanisms appear to produce similar diseases. However, evidence that any of these mechanisms are actually responsible for xenobiotic-induced human autoimmune disease is still largely lacking, and the potential for numerous and as yet unidentified mechanisms also exists.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10502539      PMCID: PMC1566247          DOI: 10.1289/ehp.99107s5737

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  82 in total

Review 1.  Drug-induced lupus.

Authors:  R L Yung; B C Richardson
Journal:  Rheum Dis Clin North Am       Date:  1994-02       Impact factor: 2.670

2.  Decreased mRNA levels coding for poly(ADP-ribose) polymerase in lymphocytes of patients with SLE.

Authors:  J S Lee; B L Haug; J T Sibley
Journal:  Lupus       Date:  1994-04       Impact factor: 2.911

Review 3.  Sex hormones, glucocorticoids and autoimmunity: facts and hypotheses.

Authors:  J A Da Silva
Journal:  Ann Rheum Dis       Date:  1995-01       Impact factor: 19.103

Review 4.  Fas and Fas ligand: lpr and gld mutations.

Authors:  S Nagata; T Suda
Journal:  Immunol Today       Date:  1995-01

5.  Mechanism of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo.

Authors:  R L Yung; J Quddus; C E Chrisp; K J Johnson; B C Richardson
Journal:  J Immunol       Date:  1995-03-15       Impact factor: 5.422

Review 6.  The basis of autoimmunity: Part I. Mechanisms of aberrant self-recognition.

Authors:  A N Theofilopoulos
Journal:  Immunol Today       Date:  1995-02

7.  Lymphocyte function-associated antigen 1 overexpression and T cell autoreactivity.

Authors:  B Richardson; D Powers; F Hooper; R L Yung; K O'Rourke
Journal:  Arthritis Rheum       Date:  1994-09

Review 8.  Transforming growth factor beta: the good, the bad, and the ugly.

Authors:  S M Wahl
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

9.  Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B'-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity.

Authors:  J A James; T Gross; R H Scofield; J B Harley
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

10.  Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes.

Authors:  L A Casciola-Rosen; G Anhalt; A Rosen
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more
  12 in total

Review 1.  Drug-induced lupus erythematosus: incidence, management and prevention.

Authors:  Christopher Chang; M Eric Gershwin
Journal:  Drug Saf       Date:  2011-05-01       Impact factor: 5.606

2.  Bisphenol A (BPA) stimulates the interferon signaling and activates the inflammasome activity in myeloid cells.

Authors:  Ravichandran Panchanathan; Hongzhu Liu; Yuet-Kin Leung; Shuk-mei Ho; Divaker Choubey
Journal:  Mol Cell Endocrinol       Date:  2015-08-12       Impact factor: 4.102

Review 3.  T cells and B cells in lupus nephritis.

Authors:  Mary H Foster
Journal:  Semin Nephrol       Date:  2007-01       Impact factor: 5.299

4.  Promoter hypomethylation results in increased expression of protein phosphatase 2A in T cells from patients with systemic lupus erythematosus.

Authors:  Katsue Sunahori; Yuang-Taung Juang; Vasileios C Kyttaris; George C Tsokos
Journal:  J Immunol       Date:  2011-02-23       Impact factor: 5.422

Review 5.  Regaining tolerance to a self-antigen by the modified vaccination technique.

Authors:  Arpad Zsigmond Barabas; Chad Douglas Cole; Rene Lafreniere; Donald Mackay Weir
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

Review 6.  Biomarkers for kidney involvement in pediatric lupus.

Authors:  Beatrice Goilav; Chaim Putterman; Tamar B Rubinstein
Journal:  Biomark Med       Date:  2015       Impact factor: 2.851

7.  Occupational silica exposure and risk of various diseases: an analysis using death certificates from 27 states of the United States.

Authors:  G M Calvert; F L Rice; J M Boiano; J W Sheehy; W T Sanderson
Journal:  Occup Environ Med       Date:  2003-02       Impact factor: 4.402

Review 8.  Epigenetics in human autoimmunity. Epigenetics in autoimmunity - DNA methylation in systemic lupus erythematosus and beyond.

Authors:  Faith M Strickland; Bruce C Richardson
Journal:  Autoimmunity       Date:  2008-05       Impact factor: 2.815

Review 9.  Metabolic control of the epigenome in systemic Lupus erythematosus.

Authors:  Zachary Oaks; Andras Perl
Journal:  Autoimmunity       Date:  2013-10-16       Impact factor: 2.815

Review 10.  DNA damage due to oxidative stress in Chronic Obstructive Pulmonary Disease (COPD).

Authors:  Eirini Neofytou; Eleni G Tzortzaki; Argiro Chatziantoniou; Nikolaos M Siafakas
Journal:  Int J Mol Sci       Date:  2012-12-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.